As the U.S. equities market takes a breather from its recent rally, major indices like the S&P 500 have reached new highs, reflecting investor optimism amid strong corporate earnings and pro-business ...

As global markets show signs of resilience with cooling inflation and strong bank earnings propelling stocks higher, the S&P MidCap 400 and Russell 2000 indices have notably outperformed, reflecting a ...

Fluence Energy Inc. (NASDAQ:FLNC), a leading provider of energy storage solutions, finds itself at a critical juncture as it navigates a complex landscape of market pressures, regulatory uncertainties ...

The global biologics contract development and manufacturing organization (cdmo) market size is estimated to grow by USD 16.32 ...

Schlumberger NV (NYSE:SLB) reported its fourth-quarter and full-year 2024 earnings, surpassing market expectations with an EPS of $0.92 against a forecast of $0.90. The company also exceeded revenue ...

Financially risky OS Therapies has potential with mid-stage immunotherapy for osteosarcoma, but faces funding challenges and ...

Identities must be securely created and protected, continuously validated, limited by zero trust principles, and continuously ...

The U.S. FDA is to temper the alert it put out in November 2023 pointing to a potential risk of CAR T therapies causing de novo malignancies. “There was this issue of possible safety concerns with T ...

Collaboration is needed. Security solutions should pull information together from siloed security sources and make fast, ...

Figure 2: Kendal Project location map with Red Canyon claims.

4DMT is a late-stage biotechnology company focused on unlocking the full potential of genetic medicines to treat large market diseases in ophthalmology and pulmonology. 4DMT's proprietary invention ...